130 related articles for article (PubMed ID: 14661)
21. Enzyme induction and beta-adrenergic receptor blocking drugs.
Branch RA; Herman RJ
Br J Clin Pharmacol; 1984; 17 Suppl 1(Suppl 1):77S-84S. PubMed ID: 6146342
[TBL] [Abstract][Full Text] [Related]
22. Influence of mild thyroid dysfunction on antipyrine clearance and metabolite formation in man.
Teunissen MW; van der Veen EA; Doodeman PJ; Breimer DD
Eur J Clin Pharmacol; 1984; 27(1):99-103. PubMed ID: 6489432
[TBL] [Abstract][Full Text] [Related]
23. The effect of hypothyroidism and thyrotoxicosis on thyroxine metabolism in the rat.
Cullen MJ; Doherty GF; Ingbar SH
Endocrinology; 1973 Apr; 92(4):1028-33. PubMed ID: 4119675
[No Abstract] [Full Text] [Related]
24. Absorption of propranolol and practolol in Coeliac disease.
Parsons RL; Kaye CM; Raymond K; Trounce JR; Turner P
Gut; 1976 Feb; 17(2):139-43. PubMed ID: 1261884
[TBL] [Abstract][Full Text] [Related]
25. Comparison of the beta-adrenoceptor blocking properties and pharmacokinetics of SL 75212 and propranolol in man [proceedings].
Bianchetti G; Chauvin M; Giudicelli JF; Gomeni R; Kilborn JR; Morselli PL; Richer C; Thuillez C
Br J Clin Pharmacol; 1979 Oct; 8(4):407P-708P. PubMed ID: 41559
[No Abstract] [Full Text] [Related]
26. Absorption of practolol and propranolol in dog intestinal loops in situ [proceedings].
Taylor DC; Grundy RU; Loveday BE
J Pharm Pharmacol; 1977 Dec; 29 Suppl():51P. PubMed ID: 22683
[No Abstract] [Full Text] [Related]
27. Beta-adrenoreceptor antagonists enhance the benzodiazepine-induced suppression of footshock induced fighting in mice.
Roliński Z; Kozak W
Pol J Pharmacol Pharm; 1980; 32(5):731-8. PubMed ID: 6115372
[TBL] [Abstract][Full Text] [Related]
28. Proceedings: Overflow of (14C)-practolol and (14C)-racemic propranolol from the isolated rat vas deferens.
Lewis MJ; Graham JD
Br J Pharmacol; 1974 Sep; 52(1):125P. PubMed ID: 4451780
[No Abstract] [Full Text] [Related]
29. Influence of thyroid status on plasma half-life of antipyrine in man.
Eichelbaum M; Bodem G; Gugler R; Schneider-Deters D; Dengler HJ
N Engl J Med; 1974 May; 290(19):1040-2. PubMed ID: 4821905
[No Abstract] [Full Text] [Related]
30. Pharmacodynamic studies of beta adrenergic antagonism induced in man by propranolol and practolol.
Bodem G; Brammell HL; Weil JV; Chidsey CA
J Clin Invest; 1973 Apr; 52(4):747-54. PubMed ID: 4144332
[TBL] [Abstract][Full Text] [Related]
31. Beta-adrenoreceptor blocking drugs and thyroid hormones in hyperthyroid subjects.
Jones MK; Birtwell J; Owens DR; Jones GR; Lewis M
Postgrad Med J; 1981 Apr; 57(666):207-9. PubMed ID: 6117063
[TBL] [Abstract][Full Text] [Related]
32. Beta-adrenergic receptor blocking drugs in hyperthyroidism.
Turner P
Drugs; 1974; 7(1):48-54. PubMed ID: 4134125
[No Abstract] [Full Text] [Related]
33. [Beta-blocking compounds and production of ATP in leukocytes of hyperthyroid subjects].
Jemelin M; Scazziga B; Frei J
Schweiz Med Wochenschr; 1970 Mar; 100(12):543-4. PubMed ID: 4392046
[No Abstract] [Full Text] [Related]
34. [Total exchangeable potassium in hyperthyroidism and hypothyroidism. (Studies with radioactive potassium K-42 and radioactive rubidium Rb-86)].
Gembicki M; An PS
Endokrynol Pol; 1972; 23(5):453-60. PubMed ID: 4642929
[No Abstract] [Full Text] [Related]
35. Mechanism of action of beta-adrenergic receptor blocking agents in angina pectoris: comparison of action of propranolol with dexpropranolol and practolol.
Wilson AG; Brooke OG; Lloyd HJ; Robinson BF
Br Med J; 1969 Nov; 4(5680):399-401. PubMed ID: 4390958
[TBL] [Abstract][Full Text] [Related]
36. Distribution kinetics and intestinal absorption of practolol in the rat.
Barber HE; Bourne GR
Br J Pharmacol; 1971 Mar; 41(3):513-20. PubMed ID: 4396971
[TBL] [Abstract][Full Text] [Related]
37. The kinetics of propranolol in hypothyroidism [proceedings].
Riddell JG; Neill JD; Kelly JG; McDevitt DG
Br J Clin Pharmacol; 1980 Jan; 9(1):121P. PubMed ID: 7356882
[No Abstract] [Full Text] [Related]
38. In vivo receptor binding of iodinated beta-adrenoceptor blockers.
Eckelman WC; Gibson RE; Vieras F; Rzeszotarski WJ; Francis B; Reba RC
J Nucl Med; 1980 May; 21(5):436-42. PubMed ID: 6103024
[TBL] [Abstract][Full Text] [Related]
39. [Clinical application of beta-blockaders].
Offerhaus L
Ned Tijdschr Geneeskd; 1973 May; 117(21):814-21. PubMed ID: 4150242
[No Abstract] [Full Text] [Related]
40. [Stereoselective glucuronidation of beta-blocking agents, 1-tert-butylamino-3-(2,3-dimethylphenoxy)-2-propanol (D-32) and propranolol, in animals, in vivo and in vitro].
Honma S; Ito T; Matsuki Y
Yakugaku Zasshi; 1986 May; 106(5):406-13. PubMed ID: 2876088
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
